Pharmacology bioRxiv
Blocking lymphocyte entry raises some HIV drug levels inside lymph node cells
- In mice, blocking lymphocyte entry into lymph nodes raised intracellular levels of tenofovir and efavirenz there, but not raltegravir.
- A computational model attributes this to a larger extracellular fluid volume in the node, which counterintuitively raises intracellular concentration.
- The size of the effect depends on how quickly each drug equilibrates between extracellular and intracellular spaces.
A higher whole-node number is not the same as more drug where the virus replicates. A raw intracellular concentration can move when the extracellular volume shifts, without any change in exposure inside infected cells. Cell-sorted intranodal measurements are needed before this is treated as a PK lever, along with a realistic view of how a trafficking blocker would ever sit alongside ART.
Paper: bioRxiv ↗ Effects Of Lymphocyte Trafficking on Antiretroviral Drug Distribution within the Lymph Node